January 27, 2015 marks the date
that a formal request was submitted to the FDA to assemble a committee to seek
approval for clinical trials; testing egg and zygote modification within in
vitro fertilization. The goal of this specific technique is to eradicate the
transmission of specific mitochondrial diseases between the mother and child.